Proteomics is revolutionizing aging research by analyzing how proteins change over time, offering a deeper understanding of biological age beyond chronological years and revealing the unique aging patterns of different organs.
This infographic explores how a protein detection assay – which outperforms antibody-based proteomics approaches – can unlock crucial insights for developing targeted treatments and enhancing our understanding of aging and disease progression.
Download this infographic to learn more about:
- The difference between chronological aging and biological age
- A platform that can accurately predict cognitive decline
- How to measure thousands of proteins at high accuracy, even with low abundance
How Proteomics is
Transforming Aging Research
Leveraging the power of the SomaScan®
Assay
to unlock new insights into organ-specific aging
Chronological vs.
Biological Age
When we think about aging, we don’t just count the years –
we also look at how our bodies change over time.
Our chronological age tells us how long we’ve been alive, but it
doesn’t capture the full story of our health and vitality. Biological
age, on the other hand, offers a deeper look at how our bodies
are truly aging.
Read on to explore how cutting-edge research
in proteomics is shaping our understanding of aging.
Proteomics
in Aging Research
Measuring how proteins change over time and in response to
factors like genetics, lifestyle and environment helps us better
understand biological age. Proteomic research can also reveal
the unique aging patterns of different organs and provide insights
that help decipher the disease mechanisms and protein networks
involved in therapeutic development.
Pioneering Proteomic
Aging Research
Groundbreaking research by Tony Wyss-Coray, PhD, at Stanford University reveals that proteomic
changes occur in nonlinear patterns during distinct life stages. This has profound implications for
understanding aging and disease progression.
Wyss-Coray’s team discovered that organs age on unique
trajectories. Accelerated aging in one organ can increase
mortality risk, even without visible disease symptoms. This
insight is crucial for developing targeted treatments.
Read more in our blog:
Blood proteins reveal biological age
of human organs to help track health and disease
How the human plasma proteome
changes with age
Learn more in this webinar:
Young Blood for Old Brains
and the Quest to Slow Brain Aging
Read about it in this Nature publication:
Organ aging signatures in the
plasma proteome track health and disease
Biological age
For Research Use Only. Not for use in diagnostic procedures.
Limited Use Label License and other terms may apply: www.standardbio.com/legal/salesterms. Patent and License Information: www.standardbio.com/legal/notices. Trademarks: www.standardbio.com/legal/trademarks.
SomaLogic, SomaScan and associated logo are trademarks owned by SomaLogic Operating Co. Inc., a wholly owned subsidiary of Standard BioTools Inc. Patent and Trademarks: https://somalogic.com/list-of-patents/.
Any other trademarks are the sole property of their respective owners. ©2024 Standard BioTools Inc. (f.k.a. Fluidigm Corporation). All rights reserved.
Chronological age
Precision Insights With
the SomaScan Platform
The SomaScan Assay delivers unmatched precision, allowing
researchers to measure thousands of proteins with high
accuracy, even at low abundance. This reliability is critical for
tracking subtle proteomic changes over time and across studies,
ensuring consistent and reproducible findings. In aging research,
where small changes can have significant implications, you can
trust that the SomaScan Assay provides data you can rely on.
See how SomaScan technology works:
Watch this video
202 proteins
linked to brain
aging
250% increased
risk of heart failure
with accelerated
heart aging
Kidney aging
proteins predict
chronic kidney
disease
Liver aging
proteins correlated
with metabolic
health
Predictive Power
of the SomaScan
Platform in Clinical
Research
Using the SomaScan Assay, researchers linked 202
proteins to brain aging, predicting cognitive decline as
accurately as leading Alzheimer’s biomarkers. Similar
insights were found for heart aging, highlighting the
platform’s predictive power in clinical research.
See how the SomaScan Assay can propel your
aging research in this application note:
Identify Protein Biomarkers
for Aging Research With the SomaScan Assay
Unlock the Potential of
Proteomics in Aging Research
